comparemela.com
Home
Live Updates
Novel IL-17 Inhibitor Passes Mid-Stage Test in Psoriatic Art
Novel IL-17 Inhibitor Passes Mid-Stage Test in Psoriatic Art
Novel IL-17 Inhibitor Passes Mid-Stage Test in Psoriatic Arthritis
Phase II results suggest drug could outperform existing agents
Related Keywords
China ,
Germany ,
Sweden ,
Copenhagen ,
Køavn ,
Denmark ,
Frankfurt ,
Brandenburg ,
Swedish ,
Frank Behrens ,
John Gever ,
European Alliance Of Associations ,
American College Of Rheumatology ,
University Hospital Fraunhofer Institute For Translational Medicine ,
American College ,
University Hospital ,
Fraunhofer Institute ,
Translational Medicine ,
European Alliance ,
Psoriasis Area ,
Severity Index ,
Managing Editor ,